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On the basis of the Law on Medicines and Medical Devices of the Republic of 
Serbia, a magistral medicine means a medicine prepared in the pharmacy accor-
ding to a prescription (formula) for an individual patient - user. In practice, the more 
need is for ex tempore production of vaginal preparations in the pharmacy and ga-
lenic laboratory. Due to the small number of registered vaginal gel products on the 
world market, and even less on our own market, their production in the pharmacies 
is very important. 
The aim of this study was to examine the possibilities of development the 
vaginal gel carriers with different hydrophilic polymers, in the pharmacy, in accor-
dance with the requirements of the European Pharmacopoeia. For their production 
we used three different mediums for gelation: Carbopol® 940, Carbopol® Ultrez 10 
and Pemulen® TR 1 NF. 
All formulations show similar organoleptic properties during the observed 
period of time. Measured pH values of carrier formulations do not differ significan-
tly compared to the normal pH values of vaginal fluid. Optimal value for viscosity 
has a formulation A1 (formulation with Carbopol® 940), thus that formulation is our 
recommendation for the development of vaginal gel carrier. Because of the compli-
cated procedure of registration of the generic drug, recommended formulation for 
vaginal gel carrier, as magistral medicine, has a great importance for patients who 
require precise adjustment of therapy. 
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On the basis of the Law on Medicines and Medi-
cal Devices of the Republic of Serbia (Article 24 para-
graph 13), a magistral medicine means a medicine pre-
pared in the pharmacy according to a prescription (for-
mula) for an individual patient - user. A galenic medicine 
means a medicine prepared based on the current phar-
macopea or based on the current magistral formulae in 
the galenic laboratory, which is intended for the patients 
- users of the pharmacy or other medical institution (1). 
Regulations on the galenic drugs used in human 
medicine ("Official Gazette of RS", No. 85/2011) in the 
part List of galenic medicinal products used in human 
medicine, lists Metronidazoli mucilago vaginalis 
0.75%, which is based on the current magistral formu-
lae of the Republic of Serbia (MF2008, chapter Vagi-
nalia - Semi-solid vaginal preparations). 
In Sixth European Pharmacopoeia (Ph. Eur. 6.0) 
in its general part we can find the monograph of vagi-
nal preparations (Vaginalia). Vaginal preparations are 
liquid, semi-solid or solid preparations intended for ad-
ministration to the vagina usually in order to obtain a lo-
cal effect. They contain one or more active substances 
in a suitable carriers (basis). 
Several categories of vaginal preparations may be 
distinguished (pessaries, vaginal tablets, vaginal capsu-
les, vaginal solutions, emulsions and suspensions, tab-
lets for vaginal solutions and suspensions, semi-solid 
vaginal preparations, vaginal foams, medicated vaginal 
tampons) (2). 
Semi-solid vaginal preparations are ointments, 
creams or gels. They are often supplied in single-dose 
containers. The container is provided with a suitable 
applicator. Semi-solid vaginal preparations comply with 
the requirements of the monograph Semi-solid prepa-
rations for cutaneous application (2). 
Ph. Eur. 6.0 provides all the requirements for qu-
ality and legislation which is necessary for the product to 
comply: 
• Uniformity of dosage units (liquid and semi-solid 
single-dose vaginal preparations); 
• Uniformity of content (solid single-dose vaginal 
preparations with a content of active substance 
less than 2 mg or less than 2 per cent of the to-
tal mass); 
• Uniformity of mass (solid single-dose vaginal pre-
parations); 
• Dissolution test (demonstrate the appropriate re-
lease of the active substance(s) from solid single-
dose vaginal preparations); 
• Containers for semi-solid preparations for cuta-
neous application comply with the requirements 
for Materials used for the manufacture of conta-
iners and Containers; 
• A test method for judging the preservative pro-
perties of the formulation are provided in Effica-
cy of antimicrobial preservation; 
• Microbiological quality of pharmaceutical prepa-
rations - Category 2; 
• Sterile semi-solid preparations are prepared us-
ing materials recommendations provided in Met-
hods of preparation of sterile products (2). 
In practice, the more need is for ex tempore pro-
duction of vaginal preparations in the pharmacy and ga-
lenic laboratory. Creams and gels are commonly used 
for vaginal administration because of the better release 
of the active substance. Spreading of creams and gels 
over the vaginal mucosa is better than with other semi-
solid forms, as they can be easily mixed with vaginal flu-
id. Creams and gels can be applied by using the appli-
cator, or can be spread to the diaphragm (3). 
Vaginal gels are often the basis for spermicides 
(nonoxynol-9), metronidazole, progesterone, inductors of 
childbirth, antifungals, antiseptics, antiphlogistics, lactic 
acid, but they are also used as an "empty" gels for moi-
sturizing of dry vaginal mucosa (4). 
To ensure good therapeutic effect it is necessary 
to provide an appropriate carrier (base) of the vaginal 
gel, easy application and its prolonged contact with mu-
cous membrane (5). 
The composition and physico-chemical properti-
es of vaginal gel carriers affect the bioavailability of the 
active substance (6). Carrier must be inert, physically and 
chemically stable, non-toxic, odorless, compatible with 
medicinal substances which are incorporated into the gel. 
Also, it should not cause irritation or sensitization on the 
application site, or to slow down the course of treatment 
(4). 
It is difficult to define the ideal value of the visco-
sity of vaginal gels. The ideal vaginal gels should po-
ssess an excellent ability to cover the vaginal mucosa, 
together with adequate retention feature which allows 
retention of the formulation in situ. Several factors affe-
ct the viscosity of vaginal gels. First of all there are com-
position of gels, temperature (especially important for 
thermolabile gels), vaginal pH value, fluid that can be fo-
und in the vagina (vaginal fluid, semen) and others. Tem-
perature, pH value and interactions with fluids present in 
the vagina might cause the changes in viscosity, which 
should be taken into account when formulations are de-
signed. It was found that small variations in gel compo-
sition lead to changes in its viscosity (7). 
In current literature and in practice there is a ve-
ry small number of studies related to the development 
of semi-solid carriers for vaginal preparations in the phar-
macy. Development of new polymeric materials - gell-
ing agents, which are used to produce hydrogels for to-
pical application provides the opportunity to explore them 
in the formulations for vaginal use. Due to the small 
number of registered vaginal gel products on the world 
market, and even less on our own market, their produ-
ction in the pharmacies is very important.  
In our country, only vaginal gel with progesterone 8% is 
registered (Crinone®, Fleet Laboratories Ltd., UK) (8). 
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AIM 
 
The aim of this study was to examine the possi-
bilities for development of vaginal gel carriers with di-
fferent hydrophilic polymers, in the pharmacy, in accor-
dance with the requirements of the European Pharma-
copoeia. 
 
MATERIALS AND METHODS 
 
In this study, we used the following materials and 
reagents: 
• Carbopol® 940 (2-propenoic acid homopolymer or po-
ly(acrylic acid), Noveon, USA); 
• Carbopol® Ultrez 10 (a cross-linked poly(acrylic acid), 
Noveon, USA); 
• Pemulen® TR 1 NF (2-methylbutanoic acid homopo-
lymer, Noveon, USA); 
• Propylene glycol (Ph. Eur. 6); 
• Sodium hydroxide (Ph. Jug. IV); 
• Disodium edetate (Ph. Jug. IV); 
• Pulvis conservans (a mixture of the methylhydroxyben- 
zoate and propylhydroxybenzoate 2+1, Ph. Jug. IV); 
• Acetonitrile (Lichro Solv®, Reag. Ph. Eur., Merck); 
• Sodium dihydrogen phosphate (Ph. Jug. V); 
• Phosphoric acid, concentrated (Ph. Eur. 6); 
• Standard buffer solutions for pH meter calibration 
(pH=4.1 i pH=7.1); 
• Purified water (Ph. Jug. V); 
• Deionized water (conductivity of 0.055 μS cm-1). 
In this study we used the following instruments: 
• Laboratory scales PCB 2000-2B KERN & Sohn GmbH, 
Germany; 
• Column electronic mixer RW 16 basic IKA® - WERKE; 
• Microprocessor pH Meter HANNA Instruments; 
• Rotating viscometer Visco Basic Plus, Fungilab. 
All of the three formulations were made using the 
same procedure, at room temperature. For their produc-
tion we used three different mediums of gelation: Carbo-
pol® 940, Carbopol® Ultrez 10 and Pemulen® TR 1 NF 
(Table 1). 
Disodium edetate is dissolved in a certain volume 
of purified water (70 ml). Pulvis conservans is dissolved 
in propylene glycol and the mixture is added to an aque-
ous solution of disodium edetate. The polymer is dis-
perged in that solution. Dispersion is made by mixing 
with the laboratory mixer at 700 r/m (in order to avoid 
the collapse of polymer gel structure, which is resulting 
in loss of viscosity of the Carbopol® gel) (9). The result-
ing dispersion is opalescent, with no lumps. The solution 
of sodium hydroxide 10% (18 drops) (10) is added to 
the dispersion and mixing is continued until the homo-
geneous gel was formed. 
 
Figure 1. Column electronic mixer RW 16 basic     
IKA® - WERKE 
The samples were packed in plastic containers 
and stored in tightly closed containers, protected from 
light, at room temperature (20±5°C). 
Table 1. The formulations for vaginal gel carriers 
F o r m u l a t i o n (g) 
Constituents 
A1 A2 A3 
    Carbopol® 940 1,00 - - 
Carbopol® Ultrez 10 - 1,00 - 
Pemulen® TR 1 -  1,00 
Dinatrii edetas 0,10 0,10 0,10 
Propylenglycolum 10,0 10,0 10,0 
Natrii hydroxydi 
solutio 10% 
1,00 1,00 1,00 
Pulvis conservans 0,10 0,10 0,10 
    Aqua purificata ad 100,00 ad 100,00 ad 100,00 
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Examinat ion  of  the  organolept ic  
proper t ies  
 
In this study we observed the following organo-
leptic characteristics of gel carriers: appearance, color, 
odor, homogeneity, easiness of application, adhesive-
ness, sensibility on the skin after application, transpa-
rency, appearance of the film which formulation leaves 
on the skin. 
Easiness of application, adhesiveness and appe-
arance of the film were studied by applying carrier on the 
skin, while the other characteristics were determinated 
visually. 
Samples were observed 24h, 15 days and 30 
days after their production. Samples were kept in plastic 
containers, protected from light, at room temperature 
(20±5°C). 
 
Determinat ion  of  pH 
 
pH value of the carrier is a very important para-
meter for the development of vaginal gels. Since the 
physiological pH range in the vagina is 3.8 to 4.2, it is 
desirable that the pH value of preparation is in that ran-
ge. Stability of the constituents at a particular pH value 
is very important. Ph. Eur. 6.0 gives a description of the 
method of potentiometric determination of pH in the 
General chapters, Methods of analysis (Physical and phy-
sicochemical methods). 
Determination of pH of samples was made by di-
rect immersion of the pH meter electrode in the sample 
(as these are hydrogels with high water content). The 
measurements were performed at a temperature of 
21.7 °C, with the previous device calibration with stan-
dard buffer solutions (pH=7.1 and pH=4.1). 
  
Figure 2. Microprocessor pH Meter HANNA 
instruments and standard buffer solutions for pH  
meter calibration (pH=4.1 i pH=7.1) 
Three measurements of pH value were made for 
each sample (the whole quantity of gel is divided into 
three parts, which are packed in plastic containers, in 
order to examine the possible impact of packaging on 
the pH value). Measurements were performed 24h, 15 
days and 30 days after sample production. 
Determinat ion  of  v iscos i ty  
 
The viscosity of samples was determined by ro-
tating viscometer Visco Basic Plus, Fungilab. 
 
Figure 3. Rotating viscometer Visco Basic Plus, 
Fungilab 
Ph. Eur. 6.0 in the General chapters, Methods of 
analysis, describes the method for determining the vis-
cosity using the rotating viscometer. The principle of the 
method is to measure the force acting on a rotor when 
it rotates at a constant rotational speed in the formula-
tion. The dynamic viscosity is measured. The unit of dy-
namic viscosity is the pascal second (Pa·s). The most co-
mmonly used submultiple is the millipascal second - 
mPa·s. 
We measured the changes in viscosity of gel ca-
rriers depending on the number of revolutions per mi-
nute (RPM values). In this case, RPM can have values 
from 0.3 to 100. The measurements were performed at 
22°C. We used the spindle with the label R6 (number six 
refers to the diameter of the spindle). 
Determining the viscosity of samples was perfor-
med on the following values of RPM: 100, 60, 50, 30, 
20, 12, 10, 6, 5, 4, 3, 2.5, 2, 1.5, 1, 0.6. The highest 
accuracy was obtained at 4 rpm (45.7%). 45.7% indi-
cates the percentage of the maximum value that the de-
vice can measure with a defined spindle and number of 
revolutions and then the measured value is the nearest 
to the value of 50% of the maximum (device shows the 
most accurate value). 
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RESULTS 
Table 2. Organoleptic properties of the samples 24h, 15 days and 30 days after the preparation 
Formulation  Organoleptic properties 
A1 
Clear, homogeneous, transparent gel, with a specific smell, easy to spread, the film after 
application on skin is thin, not sticky and greasy, and cause a pleasant feeling on skin, 
gel has a semi-solid consistency, can rinse with water, gel has small air bubbles. 
A2 
Clear, homogeneous, transparent gel, with a specific smell, easy to spread, the film after 
application on skin is thin, not sticky and greasy, and cause a pleasant feeling on skin, 
gel has a semi-solid consistency, can rinse with water, with no air bubbles. 
A3 
Crystal clear, homogeneous, transparent gel, with a specific smell, easy to spread, the 
film after application on skin is thin, not sticky and greasy, and cause a pleasant feeling 
on skin, gel has a semi-solid consistency, can rinse with water, gel has small air bubbles. 
 
The results of measurements of pH values are given in Tables 3-5. 
Table 3. Results of measurements of pH values 24h after preparation 
Formulation A1 A2 A3 
pH 5,11 5,13 5,12 
Table 4. Results of measurements of pH values 15 days after preparation 
    pH value 
Formulation 
I measurement II measurement III measurement 
Average 
A1 5,12 5,11 5,13 5,12 
A2 4,70 4,69 4,68 4,69 
A3 5,15 5,27 5,27 5,23 
Table 5. Results of measurements of pH values 30 days after preparation 
    pH value 
Formulation 
I measurement II measurement III measurement 
Average 
A1 5,14 5,15 5,10 5,13 
A2 4,68 4,63 4,71 4,673 
A3 5,26 5,27 5,22 5,25 
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Changes in viscosity of formulations A1, A2 and A3, depending on the number of revolutions per minute, are 
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DISCUSSION 
 
All formulations show similar organoleptic pro-
perties during the observed period of time and meet the 
criteria required for a certain type of products (in this 
case for vaginal gels). Gel with Carbopol® Ultrez polymer 
is distinguished by its homogeneity, easier and faster 
production and the absence of air bubbles that can be 
incorporated during mixing. 
Measured pH values of the samples do not differ 
significantly compared to the normal pH of vaginal fluid 
(3.8 to 4.2) - pH values are within physiological values 
for the required application site. The results show that 
containers have no significant impact on the pH values 
of the samples. 
The viscosity of the samples decreases with in-
creasing the number of revolutions per minute (rotati-
onal speed). As the rotational speed is proportional to 
shear rate, increasing the number of revolutions, also 
increase the shear rate, but viscosity decreases. 
By comparing the values of viscosity at 4 rpm 
(45.7%), we can conclude that a maximum value of 
viscosity has the formulation with Carbopol® 940 poly-
mer, and the lowest value formulation with Carbopol® 
Ultrez polymer (A2 formulation, which is identical to the  
formulation for the vaginal gel carrier in Metronidazoli 
mucilago vaginalis 0.75% - MF2008). Also, according 
to the results, we can see that the formulation of vagi-
nal gel carrier which has the largest value of viscosity 
at the beginning of measuring, also has the largest va-





In this study we suggested the development of 
formulations for vaginal gel carriers in the pharmacy. 
The conclusion is that vaginal gel carriers whose 
properties meet the requirements of the European Phar-
macopoeia can be prepared in the pharmacy as magi-
stral medicines. Optimal value for viscosity has a formu-
lation A1 (formulation with Carbopol® 940), so that the 
formulation is our recommendation for the develop-
ment of vaginal gel carrier. 
Because of the complicated procedure for regi-
stration of the generic drug (11, 12), recommended for-
mulation for vaginal gel carrier, as magistral medicine, 
has a great importance for patients who require precise 
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Sa že tak  
 
Na osnovu Zakona o lekovima i medicinskim sredstvima koji je na snazi u našoj zemlji, magistralni 
lek je lek izrađen u apoteci na osnovu recepta (formule) za određenog bolesnika - korisnika. U praksi se 
sve više javlja potreba za ex tempore izradom vaginalnih preparata u uslovima apoteka i galenskih labo-
ratorija. Usled malog broja registrovanih preparata, tipa vaginalnih gelova, na svetskom tržištu, ali ma-
nje na našem, veoma je važna njihova magistralna izrada u uslovima apoteke. 
Cilj ovog rada bio je ispitivanje mogućnosti izrade nosača za vaginalne gelove sa različitim hidrofil-
nim gelirajućim sredstvima u uslovima apoteke u skladu sa zahtevima Evropske farmakopeje. Za njihovu 
izradu korišćena su sledeća gelirajuća sredstva: Carbopol® 940, Carbopol® Ultrez 10 i Pemulen® TR 1 NF. 
Sve tri formulacije pokazuju slična organoleptička svojstva u posmatranom vremenskom periodu. 
Izmerene pH vrednosti formulacija nosača ne odstupaju značajno u odnosu na normalnu pH vrednost va-
ginalne tečnosti. Najoptimalniji viskozitet ima formulacija A1 (sa Carbopolom® 940), koja je ujedno i naša 
preporuka za nosač u izradi vaginalnih gelova. S obzirom na komplikovan postupak registracije generi-
čkog leka, predložena formulacija nosača za vaginalne gelove, kao magistralnog leka, od velikog je zna-
čaja za primenu kod bolesnika kojima je neophodno precizno podešavanje terapije. 
 
Ključne reči: magistralni lek; nosač; vaginalni hidrogel; regulativa; viskozitet 
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